Minneapolis, MN, United States of America

Mgi Pharma, Inc.

Calculating rank

USPTO Granted Patents = 7

Trademarks = 1

Forward Citations = 420

Loading Chart...

3 inventors (with patents filed for the assignee):

Paul C Anderson (6 out of 24 patents)

Kenneth A Hibberd (6 out of 12 patents)

Trevor C McMorris (1 out of 26 patents)

7 patents: Sort by Forward Citations

1. 6222100 - Herbicide resistance in plants (2001-04-24),

2. 6211439 - Herbicide resistance in plants (2001-04-03),

3. 6211438 - Herbicide resistance in plants (2001-04-03),

4. 5723632 - Total synthesis of antitumor acylfulvenes (1998-03-03),

5. 5718079 - Herbicide resistance in plants (1998-02-17),

6. 5331107 - Herbicide resistance in plants (1994-07-19),

7. 5304732 - Herbicide resistance in plants (1994-04-19),

Company Overview

Mgi Pharma, Inc. is a pharmaceutical company that specializes in the development and commercialization of oncology and supportive care products. With a focus on improving the lives of cancer patients, Mgi Pharma, Inc. offers innovative treatments and therapies to address unmet medical needs. The company is dedicated to advancing the field of oncology through research and development, and is committed to providing high-quality, lifesaving medications to patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#246 in Minneapolis, MN

#1,122 in Minnesota

#39,950 in US

Minneapolis, MN, United States of America

Mgi Pharma, Inc.

Forward Citations = 420

3 inventors:

Paul C Anderson (6 out of 24 patents)

Kenneth A Hibberd (6 out of 12 patents)

Trevor C McMorris (1 out of 26 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mgi Pharma, Inc.. Retrieved from https://idiyas.com/company/mgi-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]